UPLC-Q Exactive Plus-MS分析高粱壳化学成分及黄嘌呤氧化酶体外抑制活性筛选

采用高效液相色谱串联四极杆静电场轨道阱质谱对高粱壳中的化学成分进行分析鉴定,并通过高效液相色谱法筛选抑制黄嘌呤氧化酶活性成分。该实验使用Hypersil GOLD C_(18)色谱柱(2.1 nm×30 nm,3μm),以0.1%甲酸水(A)-乙腈(B)进行梯度洗脱,流速1.0 m L/min,进样量10μL。质谱分析采用ESI离子源,在正离子模式下采集数据,利用Xcalibur 4.1软件结合数据库对所得数据进行分析,共鉴定出27种化学成分。对刺槐素、葛根素、芹菜素、根皮苷、异鼠李素和3,3’,4’,7-四羟基黄酮6种化学成分进行活性筛选,发现芹菜素和3,3’,4’,7-四羟基黄酮对黄嘌呤氧化酶(XO)表现出较强的抑制活性,IC_(50)分别为18.11和34.59μmol/L。

Screening Peptide Inhibitors Using Phage Peptide Library with Isocitrate Lyase in Mycobacterium tuberculosis as Target

When devoured by macrophages,Mycobacterium tuberculosis remains persistent in macrophages and gains energy through the glyoxylate bypass to maintain its long-term existence in host cells.Therefore it is possible to stop persistent infections by interdicting the glyoxylate bypass in which the isocitrate lyase（ICL） is the key rate-limiting enzyme and a persistence factor.ICL is the target of anti-TB（TB：tubercular） drugs,which could screen ICL out and effectively inhibit the activity of ICL in Mycobacterium tuberculosis,and because of this,anti-TB drugs can be used to kill persistent Mycobacterium tuberculosis.In this study,the ICL gene of the Mycobacterium tuberculosis H37Rv was cloned successfully and recombinant protein with bioactivity was obtained through the enzyme characteristic appraisal.The specific activity of the recombined ICL is 24μmol·mg-1·min-1.The recombined ICL protein was used as the target,and phages which can specifically combine to ICL were screened in the phage 7 peptide library.According to the results of the ELISA and DNA sequence detection,eventually three 7-peptide chains were synthesized.Then the peptide chains were reacted with ICL,respectively,to detect their inhibitory effects on ICL.The results show that all the three 7-peptide chains possessed varying inhibitory effects on the activity of ICL.This study provided lead compounds for the research and development of new peptide anti-TB drugs.

人乳头瘤病毒52型病毒样颗粒制备及其生物活性

[目的]利用大肠杆菌系统表达人乳头瘤病毒52型(HPV52) L1蛋白,并获得HPV52病毒样颗粒(VLPs)。[方法]优化并合成HPV52L1基因,构建p ET-30a-52L1表达载体粒,转化大肠杆菌E. coli BL21 StarTM(DE3)。经IPTG诱导表达,阳离子交换层析纯化,SDS-PAGE和Western Blotting鉴定,BALB/c小鼠免疫2次,初次后4w检测免疫血清中HPV52中和抗体滴度。[结果]获得纯度90%的HPV52L1蛋白,将获得的HPV52L1蛋白进行解组装和重组装形成VLPs,动态光散射观察到粒径约为70nm,透射电镜观察到50～60nm的均一VLPs,中和抗体滴度达25600。[结论]大肠杆菌系统表达人乳头瘤病毒52型(HPV52) L1蛋白,并经过一步柱层析纯化获得纯度达90%的L1蛋白,经解组装重组装获得粒径大小为50～60nm的VLPs,具有良好免疫原性。